Skip to content

News releases

The following are news releases and statements issued by Biosimilars Canada. News stories about biosimilars that may be of interest to readers are available here.

January 9, 2017

Biosimilars Canada Statement on Revised Canadian Guidance for Sponsors of Biosimilars

The convergence of regulatory requirements is a top priority for sponsors of biosimilar medicines as single global development programs are typical given the high R&D costs for these complex products.
Read more
March 1, 2016

IGBA call for full transparency and new timelines for impact assessment with regard to the voluntary WHO biological qualifier (BQ) proposal

Read more
Read more
April 7, 2015

Canadian Generic Pharmaceutical Association Establishes First Voice for Biosimilars In Canada

The establishment of the new CGPA Biosimilars Board signifies the focus our industry is placing on ensuring that Canada is a viable market for the production and sale of biosimilar treatments.
Read more
1 2 3